General Manager of Icon's remote planning, Huong Nguyen and Group Manager for RT Education and Training, Aidan Leong recently presented at Radformation's webinar sharing Icon's experience with the implementation of AI Contouring across 33 locations in just 20 days! Through investment in partnerships and the latest technology we're helping close the care gap and deliver advanced care to more people. Watch the webinar: https://bit.ly/4eDf9l8 Learn more about our partnership with Radformation: https://lnkd.in/g99-EjfA #AutoContour #radiotherapy #radiationoncology #healthcare #cancercare #bestcarepossible
Icon Group
Hospitals and Health Care
Brisbane, QLD 13,332 followers
Dedicated to delivering the best care possible, to as many people as possible, as close to home as possible
About us
Icon Group delivers world-leading, integrated healthcare operating in Australia, New Zealand, Singapore, Hong Kong, Mainland China, Malaysia and the United Kingdom. The Group brings together all aspects of care from day oncology to radiation oncology, chemotherapy compounding, research, and pharmacy for the benefit of patients. We are built on a strong but simple vision – to deliver the best care possible to as many people as possible, as close to home as possible. Oncology day hospital – Our day oncology division is Australia’s largest private provider of day oncology and haematology with centres nationally, and in Singapore, Hong Kong and New Zealand. Radiation oncology – Our radiation oncology division was formed via the acquisition of four key radiation oncology businesses. We have world-class radiation oncology services across our international footprint equipped with the latest in technology and treatment techniques. Chemotherapy compounding – Slade Health is one of Australia’s largest chemotherapy compounders delivering over 1000,000 infusions annually with a growing reach overseas. Pharmacy management – for Epic Pharmacy and Slade Pharmacy, Australia's leading pharmaceutical supply businesses for the hospital, oncology sectors. Research and clinical trials – deliver Australia's largest private cancer clinical trials program with a growing global reach. Icon conducts trials across medical oncology, haematology, radiation oncology and pharmacy, including investigator initiated trials. This comprehensive end-to-end service model enables us to work as one multidisciplinary team to deliver exceptional care. With a strong focus on innovation and investment in technology based solutions, as well as global partnerships with peak industry leaders such as Varian and the Union for International Cancer Control [UICC], Icon is truly at the forefront of cancer treatment.
- Website
-
http://icongroup.global/
External link for Icon Group
- Industry
- Hospitals and Health Care
- Company size
- 1,001-5,000 employees
- Headquarters
- Brisbane, QLD
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Cancer care, radiation oncology, medical oncology, pharmacy, healthcare, compounding, oncology , cancer research, clinical trials, haematology, chemotherapy compounding, hospital pharmacy, and health screening
Locations
-
Primary
level 1, 22 Cordelia St, South Brisbane
Brisbane, QLD 4101, AU
-
1 Farrer Park Station Road #09-10/11 Farrer Park Medical Centre
Singapore, Connexion 217562, SG
-
C No.2 East 3rd Ring North Road
Room A603 TYG Center
Beijing, Chaoyang District 100600, CN
-
Suite 1018, Central Building, 1-3 Pedder Street, Central
Hong Kong , HK
Employees at Icon Group
-
Jason Kempnich
Enterprise Cyber Security Architect, pragmatic solutions.
-
Judy Tan
Regional Healthcare Management and Hospital Pre-Operation Setup
-
Serena Wee
CEO - Icon ASEAN and Hong Kong
-
Rajanikar Tota
Medical Oncologist at Icon Group. Currently located at Icon Cancer Centre Rockingham.
Updates
-
🎗️ 𝗕𝗿𝗲𝗮𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝗮𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗺𝗼𝗻𝘁𝗵 🎗️ In recognition of breast cancer awareness month UK Chief Clinical Strategy Officer, Dr Penny Kechagioglou shares her insights into the changing face of breast cancer treatment. From the latest advancements in technology, AI and personalised treatments, to a focus on delivering effective multidisciplinary care, support services and research, the pace of innovation shows no signs of slowing. While challenges remain, the collaborative efforts of healthcare professionals are driving progress towards a future where breast cancer treatment is increasingly effective, less invasive and associated with significantly improved quality of life and survivorship rates. 📄 Read the full article: https://lnkd.in/gyHsz9r7 #cancercare #breastcancer #breastcancerawareness #oncology #RT #radiotherapy #healthcare
-
Congratulations to Icon Cancer Centre - Australia & New Zealand Radiation Oncologist, Dr Pat Bowden and the research team who were featured in The Australian on their landmark TRANSFORM trial recently published the five-year results of the trial in the International Journal of Cancer (IJC). The trial found that stereotactic radiation therapy for metastatic prostate cancer can delay other forms of treatment for more than five years for many patients. Icon has 97% stereotactic coverage across our global network of cancer centres and continues to invest in clinical trials and the latest technologies to advance cancer care. Learn more: https://lnkd.in/gBBtXWwq #prostatecancer #prostatecancerresearch #cancerresearch #clinicaltrial #cancercare #radiotherapy #stereotacticradiotherapy #bestcarepossible
-
🏆 𝗔𝘄𝗮𝗿𝗱𝘀 𝘀𝗲𝗮𝘀𝗼𝗻 🏆 Icon Group has demonstrated its leadership and innovation in healthcare, earning finalist nominations across four prestigious industry awards: ➡️ Health Industry Hub's Catalyst for Change Awards ➡️ South Metropolitan Health Service's Excellence Awards ➡️ Australian Institute of Management's WA Pinnacle Awards ➡️ iTnews Benchmark Awards - Security This recognition reflects our commitment to excellence and highlights the transformative role Icon plays in the healthcare industry. Congratulations to all our team members involved and good luck for awards night. Read more about these awards: https://lnkd.in/gqcpstAh #healthcare #cancercare #cancer #healthcareexcellence #healthcareinnovation Icon Cancer Centre - Australia & New Zealand
-
🌟 Recognising our pharmacy and compounding technicians 🌟 Today marks World Pharmacy Technicians and Assistants Day – which at Icon Group - not only recognises the pivotal role of our pharmacy technicians and assistants, but also our technicians across our compounding facilities. Our technicians and assistants are our partners in care, working alongside the broader healthcare team to deliver quality technical services – from processing prescriptions, compounding, dispensing and delivering medications to ensuring the smooth sunning of our pharmacy and compounding facilities - ensuring patients can receive the care they need. Thank you to all our pharmacy and compounding technicians and assistants across Icon Cancer Centre - Australia & New Zealand, Icon Cancer Centre - Singapore, Slade Pharmacy, Epic Pharmacy, and Slade Health and Pharmaxo for all the work you do every day. 👉 Swipe to hear some of our pharmacy and compounding team members’ insights about their technician and assistant roles. 📄 Read more about the role of our pharmacy and compounding technicians and how they help us deliver the best care possible: https://lnkd.in/gjvJEJBZ #RxTechDay #pharmacytechnicians #compooundingtechnicians #pharmacy #healthcare
-
Icon Cancer Centre - Australia & New Zealand CEO, Paul Fenton and National Planning and Implementation Manager, Fiona French had the honour of attending Prostate Cancer Foundation of Australia's (PCFA) Annual Parliamentary Aussie Barbie in Canberra today. PCFA announced a landmark three-year research partnership with ANZUP Cancer Trials Group Limited aimed at accelerating clinical trials and advancements in prostate cancer treatment. Prostate cancer is the most common cancer in Australia with more than 26,000 men expected to be diagnosed this year. Investment in research, screening and specialised support services has never been more important. At Icon, we're proud to be longstanding partners of PCFA and support the vital work they do. We invest in prostate cancer specialist nurses at our centres and encourage men and their families to access the foundation's services - proudly standing alongside PCFA to deliver better outcomes for men across Australia. Learn more about today's announcement: https://lnkd.in/geU6g5aR #prostatecancer #cancercare #healthcare Anne Savage
-
+1
-
We're proud to be a silver sponsor of Can Assist: Cancer Patients' Assistance Society of NSW's STRYDE 4 Day - a 10km walk from iconic Bondi Beach to Maroubra on Thursday 24 October. Participation and donations made will go towards Can Assist who help people across New South Wales access cancer treatment through practical suport services. This weekend Can Assist will double any donations made! Feel free to share with your networks and help us support cancer patients https://lnkd.in/gc9EydkD #DoubleDonationWeekend #STRYDE4 #cancercare #cancercharity
-
🌲 Best care possible – for patients, people and planet 🌲 In line with Icon Group’s commitment to sustainability, Slade Health has partnered with Greenfleet, a not-for-profit environmental organisation that has been delivering climate action for over 25 years. In an effort to care for the environment the Slade team pledged to plant native trees for every idea shared and has planted 150 trees with Greenfleet as part of their 2023 Advanced Pharmacy Australia Medicines Management Conference initiative. Learn more about this initiative and our ESG goals here: https://lnkd.in/gUNC6n_s #chemotherapycompounding #growwithslade #sustainability #ESG
-
🌟 𝗣𝗲𝗼𝗽𝗹𝗲 𝗼𝗳 𝗜𝗰𝗼𝗻 🌟 Meet Icon Cancer Centre - Australia & New Zealand's newest Site Manager, Ben Archard. Ben has been with Icon for more than 10 years, starting as an administration officer and now taking on the lead role at our new Icon Cancer Centre Noosa in sunny Queensland. Growing up in regional Victoria, Ben knows what it's like to have limited access to vital healthcare services. That's why he's dedicated to delivering an exceptional local service to the Noosa community. Read his story: https://lnkd.in/gzmj6NzJ #AtIconYouCan #Iconcareers #healthcarecareers #cancercare
-
Icon Group has become the first Australian organisation to be awarded the GCSA - The Global Quality Standard for Clinical Research Sites, and silver level Workforce Process Quality Certification (WPQC) for our clinical trials program. This dual accreditation demonstrates Icon’s exceptional commitment to the highest global best-practice research standards and our ability to deliver a quality comprehensive cancer clinical trials program that meets industry-leading benchmark standards. Read the full story: https://lnkd.in/gfRCM5Zd #cancerresearch #clinicaltrials #research #cancercare #qualityhealthcare #healthcare Icon Cancer Centre - Australia & New Zealand IAOCR - International Accrediting Organization for Clinical Research